Fergus Fleming
Directeur Technique/Scientifique/R&D chez RENALYTIX PLC
Fortune : 153 310 $ au 30/04/2024
Postes actifs de Fergus Fleming
Sociétés | Poste | Début | Fin |
---|---|---|---|
RENALYTIX PLC | Directeur/Membre du Conseil | 15/03/2018 | - |
Directeur Technique/Scientifique/R&D | 15/03/2018 | - | |
Ff Consulting Ltd. | Directeur Général | 01/06/2013 | - |
Historique de carrière de Fergus Fleming
Anciens postes connus de Fergus Fleming
Sociétés | Poste | Début | Fin |
---|---|---|---|
Oncomark Ltd.
Oncomark Ltd. Medical SpecialtiesHealth Technology Oncomark Ltd. Engages in the development and application of biomarker panels. The firm’s products include OncoMasTR and pipeline assays. The company was founded by William M. Gallagher and Steve Carl Penney in 2007 and is headquartered in Belfield, Ireland. | Corporate Officer/Principal | 01/11/2016 | 01/10/2018 |
Formation de Fergus Fleming
National University of Ireland Galway | Undergraduate Degree |
Statistiques
Internationale
Royaume-Uni | 3 |
Irlande | 3 |
Opérationnelle
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Chief Executive Officer | 1 |
Sectorielle
Technology Services | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
RENALYTIX PLC | Technology Services |
Entreprise privées | 2 |
---|---|
Ff Consulting Ltd. | |
Oncomark Ltd.
Oncomark Ltd. Medical SpecialtiesHealth Technology Oncomark Ltd. Engages in the development and application of biomarker panels. The firm’s products include OncoMasTR and pipeline assays. The company was founded by William M. Gallagher and Steve Carl Penney in 2007 and is headquartered in Belfield, Ireland. | Health Technology |
- Bourse
- Insiders
- Fergus Fleming
- Expérience